Term
|
Definition
Metformin (Glucophage)
Advantages:
-low risk of hypoglycemia
-weight neutral(possible weight loss)
-possible decrease in LDL and TG
-possible decrease in CHD
Disadvantages:
-metallic taste
-may cause gi side effects-decreased by slow titration
-Contraindicated in renal suffiency-may cause lactic acidosis |
|
|
Term
|
Definition
Drugs:
Gyburide (Micronase, Diabeta)
Glipezide (Glucotrol, XL)
Glimeperide (Amaryl)
A-
-generally well tolerated
-reduction in CV risks and mortality
D:
-weight gain
-rash
-sun sensitivity
-severe hypoglycemia-high risk in elderly and hepatic adn renl disfunction
-Glyburide has higher risk of hypoglycemia
-glipizide is preferred in elderly and renally impaired |
|
|
Term
|
Definition
Repaglinide (Prandin)
Nateglinide (Starlix)
A:
-accentuated effects around meal ingestion
-may be used in renal insufficiency
D:
-hypoglycemia and possible weight gain
-shorter half life than sulfonylureas ( more frequent admin) |
|
|
Term
Thiazolidinediones (Glitazones)
|
|
Definition
Pioglitazone (Actos)
Rosiglitazone (Avandia)
A of Pio:
-no hypoglycemia
-increase HDL, decrease TG
D of Pio:
-weight gain
-edema
-heart failure
-bone fractures
A of Avandia:
No hypoglycemia
D of Avandia:
-Increase LDL
-contraindicated in heart disease |
|
|
Term
Alpha glucosadase inhibitor |
|
Definition
Acarbos (Precose)
Glycet (Miglotol)
A:
-affective for lowering post-prandial glucose
d:
increase gas production adn gi symptoms
-contraindicated in IDD, chronic ulceration, adn partial obstruction |
|
|
Term
|
Definition
Exenatide (Byetta)
Liraglutide (Victoza)
A:
-weight reduction
D:
-NVD
*Injectable
*Long term safety unknown
*black box for thyroid tumors (Victoza) |
|
|
Term
Di-peptidyl peptidase 4 inhibitors (DPP-4) |
|
Definition
Sitagliptin (Januvia)
Saxagliptin (Onglyza)
Vildagliptin (Tradjenta)
A:
-no hypolglycemia
-weight neutral
D:
-occasional reports of urticaria/ angiodema
-cases of pancreatitis seen
*Long term safety unknown |
|
|
Term
|
Definition
Pramlintade (Symlin)
A:
-used in type 1 and type 2 dm
D:
-subcutaneous injection
-only as an adjunct to insulin
-insulin dosage reduction required upon intiation
-never mix Symlin and insulin in same syringe
-severe hypoglycemia-especially in type 1
-nausea-titrate gradually
-anorexia |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Rosiglitazone/Glimepiride |
|
|
Term
|
Definition
|
|
Term
|
Definition
Lispro (Humulog)
Aspart (Novolog)
Glulisine (Apidra) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Lantus (Glargine)
Levomir (Detmir) |
|
|